Generalized Anxiety Disorder
📧 Sign up to get email alerts when something new happens for Generalized Anxiety Disorder.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2013-12-17FDA Approved: DULOXETINE — Original Application (Actavis Pharma, Inc.)
FDA approved Actavis Pharma, Inc.'s original application for a generic duloxetine product. The approval makes low-cost generic duloxetine av…
-
FDA approval · 2013-12-11FDA Approved: DULOXETINE — Original Application (Aurobindo Pharma Limited)
FDA approved the original application for a generic duloxetine hydrochloride product from Aurobindo Pharma Limited.
-
FDA approval · 2013-12-11FDA Approved: DULOXETINE — Original Application (MARKSANS PHARMA LIMITED)
FDA approves duloxetine hydrochloride generic by Marksans Pharma Limited under an Original ANDA (ANDA 090723).
-
FDA approval · 2013-12-11FDA Approved: DULOXETINE — Original Application (Sun Pharmaceutical Industries, Inc.)
FDA approves Sun Pharmaceutical Industries' original application for a generic duloxetine product (DULOXETINE). This approval allows the mar…
-
FDA approval · 2013-12-11FDA Approved: DULOXETINE — Original Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals' generic duloxetine under an Original Application, authorizing a generic version of the reference duloxet…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2013-09-19FDA Approved: ALPRAZOLAM — Supplemental Application (Aurobindo Pharma Limited)
FDA approved the supplemental application for Alprazolam from Aurobindo Pharma Limited (generic alprazolam). The approval pertains to a supp…
-
FDA approval · 2013-07-31FDA Approved: ESCITALOPRAM — Supplemental Application (Jubilant Cadista Pharmacuticals Inc.)
FDA approves Jubilant Cadista's supplemental application for escitalopram oxalate (generic escitalopram), expanding availability of a generi…
-
FDA approval · 2013-07-31FDA Approved: ESCITALOPRAM OXALATE — Supplemental Application (Quallent Pharmaceuticals Health LLC)
The FDA approved a supplemental application for escitalopram oxalate (generic antidepressant) from Quallent Pharmaceuticals Health LLC.
-
FDA approval · 2013-07-26FDA Approved: DOXEPIN — Original Application (Actavis Pharma, Inc.)
The FDA approved Actavis Pharma, Inc.'s generic doxepin as an original ANDA, providing a generic option for this antidepressant.
-
FDA approval · 2013-06-28FDA Approved: PAROXETINE — Original Application (Padagis US LLC)
FDA approved a paroxetine product from Padagis US LLC under an original application.
-
FDA approval · 2013-06-12FDA Approved: ESCITALOPRAM ORAL SOLUTION — Original Application (Chartwell RX, LLC)
FDA approved a generic escitalopram oral solution from Chartwell RX, LLC under an Original Application (ANDA). It is indicated for major dep…
-
FDA approval · 2013-06-10FDA Approved: ESCITALOPRAM — Supplemental Application (Accord Healthcare Inc.)
FDA approved Accord Healthcare Inc.'s supplemental application for escitalopram (generic) under ANDA202389. This approval marks a supplement…
-
FDA approval · 2013-05-31FDA Approved: ESCITALOPRAM OXALATE — Supplemental Application (Rising Pharma Holdings, Inc.)
FDA approved a supplemental application for escitalopram oxalate from Rising Pharma Holdings, Inc., approving a generic version under the AN…
-
FDA approval · 2013-05-31FDA Approved: ESCITALOPRAM — Supplemental Application (Aurobindo Pharma Limited)
FDA approved the supplemental application for escitalopram oxalate by Aurobindo Pharma Limited, enabling continued generic production and di…
-
FDA approval · 2013-05-21FDA Approved: ESCITALOPRAM OXALATE — Supplemental Application (Macleods Pharmaceuticals Limited)
FDA approved a supplemental application for escitalopram oxalate from Macleods Pharmaceuticals Limited, allowing the generic product to be m…
-
FDA approval · 2013-05-20FDA Approved: ESCITALOPRAM — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for ESCITALOPRAM (escitalopram oxalate) from Sun Pharmaceutical Industries, Inc., approving this gen…
-
FDA approval · 2013-02-28FDA Approved: PREGABALIN — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for pregabalin from Mylan Pharmaceuticals Inc. The approval confirms regulatory status of the generi…
-
FDA approval · 2012-12-18FDA Approved: PAXIL — Supplemental Application (Apotex Corp)
The FDA approved a supplemental application for Paxil (paroxetine hydrochloride) submitted by Apotex Corp.
-
FDA approval · 2012-12-18FDA Approved: EFFEXOR XR — Supplemental Application (Viatris Specialty LLC)
The FDA approved a supplemental application for Effexor XR (venlafaxine hydrochloride) submitted by Viatris Specialty LLC.
-
FDA approval · 2012-12-11FDA Approved: VENLAFAXINE HYDROCHLORIDE — Supplemental Application (Vertical Pharmaceuticals, LLC)
The FDA approved a supplemental application for venlafaxine hydrochloride from Vertical Pharmaceuticals, LLC, expanding the drug’s approved …
-
FDA approval · 2012-11-29FDA Approved: ALPRAZOLAM — Supplemental Application (Sandoz Inc)
FDA approved a supplemental application for alprazolam from Sandoz Inc under an Abbreviated New Drug Application, resulting in an approved a…
-
FDA approval · 2012-11-29FDA Approved: ALPRAZOLAM — Supplemental Application (Sandoz Inc)
The FDA approved a supplemental application for Alprazolam by Sandoz Inc, a generic benzodiazepine used to treat anxiety disorders such as g…
-
FDA approval · 2012-09-19FDA Approved: VENLAFAXINE — Supplemental Application (BluePoint Laboratories)
FDA approval of a supplemental application for venlafaxine from BluePoint Laboratories (ANDA).
-
FDA approval · 2012-09-19FDA Approved: VENLAFAXINE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for venlafaxine hydrochloride from Aurobindo Pharma Limited, resulting in approval of a generic venl…
-
FDA approval · 2012-09-19FDA Approved: VENLAFAXINE HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for venlafaxine hydrochloride submitted by Teva Pharmaceuticals USA, Inc., resulting in changes to t…